MINNEAPOLIS--(BUSINESS WIRE)--Nov. 7, 2013--
Piper
Jaffray (NYSE: PJC) is pleased to announce the hiring of Josh
Schimmer, MD as a managing director and senior research analyst based in
the firm’s New York office. Schimmer will be focused on small- and
mid-cap biotechnology companies with specific emphasis in core
therapeutic areas, commercialization and strategic partnerships.
Schimmer brings more than 10 years of experience to Piper Jaffray. He
joined the firm from Lazard Capital Markets, and was previously at Cowen
& Co., Leerink Swann, Deutsche Banc and Davidson Kempner. Schimmer holds
a doctorate of medicine from the University of Toronto and a Master of
Business Administration degree from Harvard Business School.
"Piper Jaffray has a strong team of healthcare professionals and we are
excited to be adding another research specialist in biotechnology with
Josh's hire," commented Steph
Wissink, co-director of equity research for Piper Jaffray. "With
increased emphasis on core growth areas of biotech, we see opportunities
to serve the needs of our clients and build upon our market-leading
healthcare platform."
Piper Jaffray has a total of 30
senior research analysts located in Minneapolis, New York, San
Francisco and Chicago. The firm provides coverage on approximately 575
companies in the following key sectors: business & financial
services; clean technology & industrial growth; consumer; healthcare;
and technology, media & telecommunications.
About Piper Jaffray
Piper Jaffray is a leading investment
bank and asset management firm serving clients in the U.S. and
internationally. Proven advisory teams combine deep industry, product
and sector expertise with ready access to capital. Founded in 1895, the
firm is headquartered in Minneapolis and has offices across the United
States and in London and Zurich. www.piperjaffray.com
Since 1895. Member NYSE and SIPC.
© 2013 Piper Jaffray & Co.
Source: Piper Jaffray Companies
Piper Jaffray Companies
Pamela Steensland, +1 612-303-8184
